Anastrozole

E-mail: [email protected] Skype: ycgc1992 Anastrozole CAS :120511-73-1 MF: C17H19N5 MW: 293.37 Assay: 99% Appearance: white crystalline powder Package: foil bag Anastrozole is third-generation aromatase inhibitor. For the treatment of postmenopausal patients with advanced breast cancer. Anastrozole is a non-steroidal aromatase-inhibiting drug approved for treatment of breast cancer after surgery, as well as for metastasis in both pre and post-menopausal women. The severity of breast cancer is increased by estrogen, as sex hormones cause hyperplasia, and differentiation at estrogen receptor sites. Anastrozole works by inhibiting the synthesis of estrogen.